Enarodustat
未知生产厂商
Enarodustat is under investigation in clinical trial NCT02581124 (Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease).
Enarodustat is under investigation in clinical trial NCT02581124 (Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease).
适用于非透析的成人慢性肾脏病（CKD）患者的贫血治疗。
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
